Meridian Bioscience's Q1 Revenues Rise 8 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported an 8 percent hike in its fiscal first-quarter revenues helped along by its illumigene molecular diagnostic franchise.

For the three months ended Dec. 31, 2011, sales rose to $40.3 million, compared to $37.3 million in the year-ago period, but fell short of consensus analyst estimates of $43.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.